| dc.contributor.author | Ergözen, Serkan | |
| dc.date.accessioned | 2020-11-20T14:41:34Z | |
| dc.date.available | 2020-11-20T14:41:34Z | |
| dc.date.issued | 2019 | |
| dc.identifier.issn | 0952-8180 | |
| dc.identifier.issn | 1873-4529 | |
| dc.identifier.uri | https://doi.org/10.1016/j.jclinane.2018.12.019 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12809/948 | |
| dc.description | WOS: 000462694300024 | en_US |
| dc.description | PubMed ID: 30597458 | en_US |
| dc.description.abstract | The article entitled“Hyperbaric oxygen treatment resistant carbonmonoxide poisoning”by Gulcin Aydin reports a patient who could notbenefit from Hyperbaric Oxygen Treatment (HBOT) [1]. I would like toemphasise some issues which might be important for a physiciantreating a patient with severe carbon monoxide (CO) poisoning | en_US |
| dc.item-language.iso | eng | en_US |
| dc.publisher | Elsevier Science Inc | en_US |
| dc.item-rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Carbon Monoxide Poisoning | en_US |
| dc.title | Hyperbaric oxygen treatment resistant carbon monoxide poisoning | en_US |
| dc.item-type | letter | en_US |
| dc.contributor.department | MÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
| dc.contributor.institutionauthor | Ergözen, Serkan | |
| dc.identifier.doi | 10.1016/j.jclinane.2018.12.019 | |
| dc.identifier.volume | 55 | en_US |
| dc.identifier.startpage | 76 | en_US |
| dc.identifier.endpage | 76 | en_US |
| dc.relation.journal | Journal of Clinical Anesthesia | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
